Moderna: Citi says oncology optimism is priced in, cuts rating to sell
Go back to Moderna: Citi says oncology optimism is priced in, cuts rating to sell| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 245.81 +3.73 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $242.08 | 52 Week High | $0.52 | |||
| Open | $242.20 | 52 Week Low | $0.08 | |||
| Day High | $254.48 | P/E | N/A | |||
| Day Low | $239.55 | EPS | $-3.80 | |||
| Volume | 16,160,648 | |||||



